Biological roles of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Van Alphen, Lieke B ^a   Wenzel, Cory Q ^a   Richards, Michele R ^a   Fodor, Christopher ^a   Ashmus, Roger A ^a   Stahl, Martin ^b   Karlyshev, Andrey V ^c   Wren, Brendan W ^d   Stintzi, Alain ^b   Miller, William G ^e   Lowary, Todd L ^a   Szymanski, Christine M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c KINGSTON UNIVERSITY   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; MONOSACCHARIDE; PHOSPHORAMIDIC ACID DERIVATIVE; POLYSACCHARIDE; AMIDE; BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; INSECTICIDE; PHOSPHORAMIDIC ACID; PHOSPHORIC ACID; TRANSFERASE;

ARTICLE; BACTERIAL STRAIN; CACO 2 CELL LINE; CAMPYLOBACTER JEJUNI; CELL ADHESION; CELL INVASION; CELL SURFACE; CHICKEN; EPITHELIUM CELL; GALLERIA MELLONELLA; GRAM NEGATIVE BACTERIUM; INSECTICIDAL ACTIVITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PIGLET; WILD TYPE; ANIMAL; BACTERIAL CAPSULE; BACTERIUM ADHERENCE; CAMPYLOBACTERIOSIS; DRUG EFFECTS; ENZYMOLOGY; GENE INACTIVATION; GENETICS; HUMAN; LARVA; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MOTH; PHYLOGENY; PHYSIOLOGY; SWINE;

AMIDES; ANIMALS; BACTERIAL ADHESION; BACTERIAL CAPSULES; BACTERIAL PROTEINS; CACO-2 CELLS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHICKENS; GENE KNOCKOUT TECHNIQUES; HUMANS; INSECTICIDES; LARVA; MICROBIAL VIABILITY; MOTHS; PHOSPHORIC ACIDS; PHYLOGENY; POLYSACCHARIDES, BACTERIAL; SUS SCROFA; TRANSFERASES;

EID: 84899874143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087051     Document Type: Article

References (47)

1. Allos BM (2001) Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis 32: 1201-1206.
2. Humphrey T, O'Brien S, Madsen M (2007) Campylobacters as zoonotic pathogens: a food production perspective. Int J Food Microbiol 117: 237-257. (Pubitemid 46978410)
3. Friedman CR, Hoekstra RM, Samuel M, Marcus R, Bender J, et al. (2004) Risk factors for sporadic Campylobacter infection in the United States: A case-control study in FoodNet sites. Clin Infect Dis 38 Suppl 3: S285-296. (Pubitemid 38553336)
4. Mishu B, Blaser MJ (1993) Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barre syndrome. Clin Infect Dis 17: 104-108. (Pubitemid 23197573)
5. Karlyshev AV, Linton D, Gregson NA, Lastovica AJ, Wren BW (2000) Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol Microbiol 35: 529-541. (Pubitemid 30085271)
6. Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, et al. (2001) A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol Microbiol 40: 769-777. (Pubitemid 32453128)
7. Szymanski CM, Michael FS, Jarrell HC, Li J, Gilbert M, et al. (2003) Detection of conserved N-linked glycans and phase-variable lipooligosaccharides and capsules from campylobacter cells by mass spectrometry and high resolution magic angle spinning NMR spectroscopy. J Biol Chem 278: 24509-24520. (Pubitemid 37548603)
8. McNally DJ, Jarrell HC, Li J, Khieu NH, Vinogradov E, et al. (2005) The HS:1 serostrain of Campylobacter jejuni has a complex teichoic acid-like capsular polysaccharide with nonstoichiometric fructofuranose branches and O-methyl phosphoramidate groups. FEBS J 272: 4407-4422. (Pubitemid 41284414)
9. McNally DJ, Jarrell HC, Khieu NH, Li J, Vinogradov E, et al. (2006) The HS:19 serostrain of Campylobacter jejuni has a hyaluronic acid-type capsular polysaccharide with a nonstoichiometric sorbose branch and O-methyl phosphoramidate group. FEBS J 273: 3975-3989. (Pubitemid 44253652)
10. McNally DJ, Lamoureux MP, Karlyshev AV, Fiori LM, Li J, et al. (2007) Commonality and biosynthesis of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni. J Biol Chem 282: 28566-28576. (Pubitemid 47606035)
11. Sorensen MC, van Alphen LB, Harboe A, Li J, Christensen BB, et al. (2011) Bacteriophage F336 recognizes the capsular phosphoramidate modification of Campylobacter jejuni NCTC11168. J Bacteriol 193: 6742-6749.
12. Sorensen MC, van Alphen LB, Fodor C, Crowley SM, Christensen BB, et al. (2012) Phase Variable Expression of Capsular Polysaccharide Modifications Allows Campylobacter jejuni to Avoid Bacteriophage Infection in Chickens. Front Cell Infect Microbiol 2: 11.
13. Miyamoto T, Kasagami T, Asai M, Yamamoto I (1999) A novel bioactivation mechanism of phosphoramidate insecticides. Pesticide Biochemistry and Physiology 63: 151-162. (Pubitemid 29405349)
14. Champion OL, Karlyshev AV, Senior NJ, Woodward M, La Ragione R, et al. (2010) Insect Infection Model for Campylobacter jejuni Reveals That O-methyl Phosphoramidate Has Insecticidal Activity. Journal of Infectious Diseases 201: 776-782.
15. Maue AC, Mohawk KL, Giles DK, Poly F, Ewing CP, et al. (2013) The Polysaccharide Capsule of Campylobacter jejuni Modulates the Host Immune Response. Infect Immun 81: 665-672.
16. van Vliet AH, Wooldridge KG, Ketley JM (1998) Iron-responsive gene regulation in a Campylobacter jejuni fur mutant. J Bacteriol 180: 5291-5298. (Pubitemid 28471523)
17. Oelschlaeger TA, Guerry P, Kopecko DJ (1993) Unusual microtubule- dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii. Proc Natl Acad Sci U S A 90: 6884-6888. (Pubitemid 23207318)
18. Blaser MJ, Smith PF, Kohler PF (1985) Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. Journal of Infectious Diseases 151: 227-235. (Pubitemid 15155285)
19. Sheppard SK, McCarthy ND, Falush D, Maiden MC (2008) Convergence of Campylobacter species: implications for bacterial evolution. Science 320: 237-239. (Pubitemid 351521420)
20. Wilson DJ, Gabriel E, Leatherbarrow AJ, Cheesbrough J, Gee S, et al. (2009) Rapid evolution and the importance of recombination to the gastroenteric pathogen Campylobacter jejuni. Mol Biol Evol 26: 385-397.
21. Silipo A, Molinaro A, Sturiale L, Dow JM, Erbs G, et al. (2005) The elicitation of plant innate immunity by lipooligosaccharide of Xanthomonas campestris. J Biol Chem 280: 33660-33668. (Pubitemid 41397168)
22. Vinogradov E, Kubler-Kielb J, Korenevsky A (2008) The structure of the carbohydrate backbone of the LPS from Shewanella spp. MR-4. Carbohydr Res 343: 2701-2705.
23. Kanipes MI, Papp-Szabo E, Guerry P, Monteiro MA (2006) Mutation of waaC, encoding heptosyltransferase I in Campylobacter jejuni 81-176, affects the structure of both lipooligosaccharide and capsular carbohydrate. J Bacteriol 188: 3273-3279.
24. Aspinall GO, McDonald AG, Pang H (1992) Structures of the O chains from lipopolysaccharides of Campylobacter jejuni serotypes O:23 and O:36. Carbohydr Res 231: 13-30.
25. Bleumink-Pluym NM, van Alphen LB, Bouwman LI, Wosten MM, van Putten JP (2013) Identification of a Functional Type VI Secretion System in Campylobacter jejuni Conferring Capsule Polysaccharide Sensitive Cytotoxicity. PLoS Pathog 9: e1003393.
26. Forsgren A, McLean RH, Michael AF, Quie PG (1975) Studies of the alternate pathway in chelated serum. J Lab Clin Med 85: 904-912.
27. Dingle KE, Colles FM, Falush D, Maiden MC (2005) Sequence typing and comparison of population biology of Campylobacter coli and Campylobacter jejuni. J Clin Microbiol 43: 340-347. (Pubitemid 40096321)
28. Rossi M, Debruyne L, Zanoni RG, Manfreda G, Revez J, et al. (2009) Campylobacter avium sp. nov., a hippurate-positive species isolated from poultry. Int J Syst Evol Microbiol 59: 2364-2369.
29. Fouts DE, Mongodin EF, Mandrell RE, Miller WG, Rasko DA, et al. (2005) Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. PLoS Biol 3: e15.
30. Aabenhus R, On SL, Siemer BL, Permin H, Andersen LP (2005) Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data. J Clin Microbiol 43: 5091-5096. (Pubitemid 41484010)
31. Zanoni RG, Debruyne L, Rossi M, Revez J, Vandamme P (2009) Campylobacter cuniculorum sp. nov., from rabbits. Int J Syst Evol Microbiol 59: 1666-1671.
32. Perez GI, Hopkins JA, Blaser MJ (1985) Antigenic heterogeneity of lipopolysaccharides from Campylobacter jejuni and Campylobacter fetus. Infect Immun 48: 528-533. (Pubitemid 15097728)
33. van Bergen MA, Dingle KE, Maiden MC, Newell DG, van der Graaf-Van Bloois L, et al. (2005) Clonal nature of Campylobacter fetus as defined by multilocus sequence typing. J Clin Microbiol 43: 5888-5898.
34. Tanner ACR, Badger S, Lai C-H, Listgarten MA, Visconti RA, et al. (1981) Wolinella gen. nov., Wolinella succinogenes (Vibrio succinogenes Wolin et al.) comb. nov., and Description of Bacteroides gracilis sp. nov., Wolinella recta sp. nov., Campylobacter concisus sp. nov., and Eikenella corrodens from Humans with Periodontal Disease. Int J Syst Bacteriol 31: 432-445. (Pubitemid 12210064)
35. Lawson AJ, On SL, Logan JM, Stanley J (2001) Campylobacter hominis sp. nov., from the human gastrointestinal tract. Int J Syst Evol Microbiol 51: 651-660. (Pubitemid 32266707)
36. Foster G, Holmes B, Steigerwalt AG, Lawson PA, Thorne P, et al. (2004) Campylobacter insulaenigrae sp. nov., isolated from marine mammals. Int J Syst Evol Microbiol 54: 2369-2373. (Pubitemid 39585431)
37. Jones MA, Marston KL, Woodall CA, Maskell DJ, Linton D, et al. (2004) Adaptation of Campylobacter jejuni NCTC11168 to high-level colonization of the avian gastrointestinal tract. Infect Immun 72: 3769-3776. (Pubitemid 38821888)
38. Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ (1988) Experimental Campylobacter jejuni infection in humans. J Infect Dis 157: 472-479. (Pubitemid 18071444)
39. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, et al. (2000) The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403: 665-668. (Pubitemid 30104008)
40. Logan JM, Burnens A, Linton D, Lawson AJ, Stanley J (2000) Campylobacter lanienae sp. nov., a new species isolated from workers in an abattoir. Int J Syst Evol Microbiol 50 Pt 2: 865-872. (Pubitemid 30167536)
41. Debruyne L, On SL, De Brandt E, Vandamme P (2009) Novel Campylobacter lari-like bacteria from humans and molluscs: description of Campylobacter peloridis sp. nov., Campylobacter lari subsp. concheus subsp. nov. and Campylobacter lari subsp. lari subsp. nov. Int J Syst Evol Microbiol 59: 1126-1132.
42. Bolton FJ, Holt AV, Hutchinson DN (1984) Campylobacter biotyping scheme of epidemiological value. J Clin Pathol 37: 677-681. (Pubitemid 14123299)
43. Lawson GH, Rowland AC, Roberts L (1976) Studies on Campylobacter sputorum subspecies Mucosalis. J Med Microbiol 9: 163-171.
44. Etoh Y, Dewhirst FE, Paster BJ, Yamamoto A, Goto N (1993) Campylobacter showae sp. nov., isolated from the human oral cavity. Int J Syst Bacteriol 43: 631-639. (Pubitemid 23299814)
45. On SL, Atabay HI, Corry JE, Harrington CS, Vandamme P (1998) Emended description of Campylobacter sputorum and revision of its infrasubspecific (biovar) divisions, including C. sputorum biovar paraureolyticus, a urease-producing variant from cattle and humans. Int J Syst Bacteriol 48 Pt 1: 195-206. (Pubitemid 28144652)
46. Debruyne L, Broman T, Bergstrom S, Olsen B, On SL, et al. (2010) Campylobacter subantarcticus sp. nov., isolated from birds in the sub-Antarctic region. Int J Syst Evol Microbiol 60: 815-819.
47. Labarca JA, Sturgeon J, Borenstein L, Salem N, Harvey SM, et al. (2002) Campylobacter upsaliensis: Another pathogen for consideration in the United States. Clin Infect Dis 34: E59-60.